3SBio, Inc. (ADR) (NASDAQ:SSRX)

CAPS Rating: 2 out of 5

The Company is engaged in the research, development, manufacture and distribution of pharmaceutical products in the China.

Recs

0
Player Avatar Germanics (46.53) Submitted: 8/25/2008 2:38:54 PM : Outperform Start Price: $9.28 SSRX Score: +33.59

Small Chinese Pharmaceutical Seems promising with possible upcoming product releases. - J.P. Germanics

Featured Broker Partners


Advertisement